Santa Cruz Biotechnology delivers a wide array of DDX47 monoclonal antibodies for research focused on understanding DDX47's role in cellular processes. DDX47 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDX47, a member of the DEAD-box RNA helicase family, plays a crucial role in RNA metabolism and is involved in processes such as mRNA splicing, translation, and ribosome biogenesis. DDX47's function is vital for maintaining cellular homeostasis and regulating gene expression, making it an important target for studies related to cancer and other diseases. Understanding DDX47 mechanisms can provide insights into therapeutic strategies and potential biomarkers. Researchers worldwide rely on DDX47 monoclonal antibodies to advance their studies in RNA processing and cellular regulation. DDX47 monoclonal antibodies enable precise detection and analysis of protein expression patterns across diverse experimental conditions. DDX47 monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing scientific knowledge in RNA biology and disease research through reliable, specific detection methods.